Binding of the antagonist [ 3 H]candesartan to angiotensin II AT 1 receptor-tranfected Chinese hamster ovary cells

By Fierens F.   Vanderheyden P.M.L.   De Backer J.-P.   Vauquelin G.  

European Journal of Pharmacology, Vol. 367, Iss. 2, 1999-02 ,pp. : 413-422

Elsevier

Access to resources Recommend Favorite

The selective angiotensin AT 1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats

By Polidori C.   Ciccocioppo R.   Pompei P.   Cirillo R.   Massi M.  

European Journal of Pharmacology, Vol. 277, Iss. 2, 1995-04 ,pp. : 223-228

Elsevier

Access to resources Recommend Favorite

Candesartan: widening indications for this angiotensin II receptor blocker?

By Mendis B   Page SR  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 12, 2009-08 ,pp. : 1995-2007

Informa Healthcare

Access to resources Recommend Favorite

Effects of the insurmountable angiotensin AT 1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts

By Wang Q.-D.   Sjoquist P.-O.  

European Journal of Pharmacology, Vol. 380, Iss. 1, 1999-09 ,pp. : 13-21

Elsevier

Access to resources Recommend Favorite

Antihypertensive activity of a nonpeptide angiotensin II receptor antagonist, YM358, in rats and dogs

By Shibasaki M.   Fujimori A.   Kusayama T.   Tokioka T.   Satoh Y.   Okazaki T.   Uchida W.   Inagaki O.   Yanagisawa I.  

European Journal of Pharmacology, Vol. 335, Iss. 2, 1997-09 ,pp. : 175-184

Elsevier

Access to resources Recommend Favorite